Base Therapeutics

Novel base editor to push the limits of gene editing

Gene and Cell Therapy
Shanghai, China and Moraga, California

About the company

Incubated by Panacea, Base utilizes synthetic biology strategies and utilizes a novel base editor that can push the limits of gene editing. Additionally, it is using this base editor to edit other important cell types, NK and T cells, to create off-the-shelf cells that are able to live longer in the human body and can infiltrate solid tumors, overcoming immune suppression in the tumor microenvironment.